Evidence map›Paper›PMID 41662409›Full record

ArticlePLoS pathogens2026

Cytotoxic lymphocytes counteract viral type I interferon immune evasion.

Michael Y Schakelaar, Liling Shan, Shuang Li, Rianne G Bouma, Josefien W Hommes, Jorine G F Sanders, Jan Meeldijk, Laura L Winkler, Toine Ten Broeke, Robert F Kalejta and 1 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michael Y SchakelaarDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Liling ShanDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Shuang LiDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Rianne G BoumaDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Josefien W HommesDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Jorine G F SandersDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Jan MeeldijkDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Laura L WinklerInstitute for Molecular Virology and McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Toine Ten BroekeDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Robert F KalejtaInstitute for Molecular Virology and McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
Niels BovenschenDepartment of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-8526-4456

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viruses are recognized by host cell innate immunity through viral RNA/DNA sensing by cyclic GMP-AMP synthase (cGAS) stimulator of interferon genes (STING). However, many viruses evade cGAS-STING signaling and antiviral IFN-β response. Here, we show that natural killer (NK) cells counteract immune evasion of type I interferon response upon human cytomegalovirus (HCMV) infection. NK cells enhance IFN-β response in virus-infected cells more efficiently than perforin-knockout and GrM-knockout NK cells. Mechanistically, GrM cleaves viral pp71 into two fragments, the first, like full-length pp71, still inhibits cGAS-STING-IFN-β response but is rapidly degraded by the proteasome, and the second fragment that rather augments IFN-β and outperforms full-length pp71 inhibition of STING. NK cells cannot enhance IFN-β response in cells infected with HCMV that harbors a pp71 with a mutated GrM cleavage site. We conclude that NK cells use GrM to counteract cytomegaloviral innate immune evasion through pp71-mediated inhibition of cGAS-STING-IFN-β innate immune response.

Indexed as

CytomegalovirusCytomegalovirus InfectionsImmune EvasionInterferon Type IKiller Cells, NaturalcGAS-STING Signaling PathwayCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseHumansImmunity, InnateInterferon-betaSignal TransductionSTING ProteinCyclic Guanosine Monophosphate-Adenosine Monophosphate SynthaseInterferon-betaInterferon Type ISTING Protein

Identifiers

PMID41662409
PMCPMC12912695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.